Stock listing
NASDAQ:PYXS Pyxis Oncology, Inc. Stock
Home listing (NASDAQ) of Pyxis Oncology, Inc.
Follow Pyxis Oncology, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:PYXS
$1.76 USD +0.08 (+4.8%)
Close on Oct 19, 2026
- Day range
- $1.68 – $1.79 USDOct 19, 2026
- Volume
- 1.02M sharesOct 19, 2026
- Market cap
- $210.2M USDAt the close on Oct 19, 2026 · price × 119.5M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PYXS · Home | $1.76 USD | +0.08 (+4.8%) | 1,016,328 | $1.71 | $1.79 | $1.675 | $1.68 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:PYXS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.76 | +0.08 | +4.8% | $1.71 | $1.79 | $1.675 | 1,016,328 | |
| $1.68 | -0.12 | -6.7% | $1.79 | $1.79 | $1.66 | 908,231 | |
| $1.80 | +0.01 | +0.6% | $1.79 | $1.84 | $1.75 | 545,678 | |
| $1.79 | -0.06 | -3.2% | $1.82 | $1.88 | $1.735 | 1,558,143 | |
| $1.85 | -0.16 | -8.0% | $1.99 | $1.998 | $1.85 | 898,883 | |
| $2.01 | -0.02 | -1.0% | $2.03 | $2.08 | $1.99 | 505,672 | |
| $2.03 | +0.04 | +2.0% | $1.99 | $2.06 | $1.98 | 950,415 | |
| $1.99 | -0.02 | -1.0% | $2.03 | $2.03 | $1.902 | 1,097,194 | |
| $2.01 | -0.01 | -0.5% | $2.02 | $2.086 | $2.00 | 957,800 | |
| $2.02 | -0.22 | -9.8% | $2.22 | $2.22 | $2.00 | 1,403,400 | |
| $2.24 | +0.10 | +4.7% | $2.12 | $2.26 | $2.05 | 1,515,100 | |
| $2.14 | -0.05 | -2.3% | $2.21 | $2.31 | $2.10 | 1,996,600 | |
| $2.19 | -0.14 | -6.0% | $2.31 | $2.31 | $2.19 | 2,602,300 | |
| $2.33 | -0.57 | -19.7% | $2.375 | $2.41 | $2.12 | 8,149,500 | |
| $2.90 | 0.00 | 0.0% | $2.94 | $2.94 | $2.83 | 335,500 | |
| $2.90 | +0.04 | +1.4% | $2.81 | $2.91 | $2.75 | 368,100 | |
| $2.86 | -0.06 | -2.1% | $2.91 | $2.92 | $2.785 | 609,700 | |
| $2.92 | -0.30 | -9.3% | $3.22 | $3.25 | $2.86 | 875,300 | |
| $3.22 | -0.135 | -4.0% | $3.36 | $3.36 | $3.20 | 433,600 | |
| $3.355 | +0.165 | +5.2% | $3.21 | $3.405 | $3.19 | 479,800 | |
| $3.19 | -0.14 | -4.2% | $3.38 | $3.38 | $3.19 | 632,800 | |
| $3.33 | -0.08 | -2.3% | $3.38 | $3.44 | $3.33 | 563,900 | |
| $3.41 | +0.07 | +2.1% | $3.43 | $3.472 | $3.339 | 476,700 | |
| $3.34 | +0.01 | +0.3% | $3.34 | $3.42 | $3.32 | 639,900 | |
| $3.33 | -0.10 | -2.9% | $3.40 | $3.42 | $3.24 | 489,600 | |
| $3.43 | +0.22 | +6.9% | $3.21 | $3.515 | $3.21 | 699,500 | |
| $3.21 | -0.06 | -1.8% | $3.31 | $3.42 | $3.07 | 1,129,400 | |
| $3.27 | -0.11 | -3.3% | $3.42 | $3.437 | $3.18 | 738,500 | |
| $3.38 | -0.51 | -13.1% | $3.48 | $4.12 | $3.132 | 4,345,200 | |
| $3.89 | 0.00 | 0.0% | $4.00 | $4.15 | $3.845 | 1,375,600 | |
| $3.89 | +0.325 | +9.1% | $3.53 | $4.05 | $3.515 | 2,230,600 | |
| $3.565 | -0.185 | -4.9% | $3.71 | $3.74 | $3.45 | 812,100 | |
| $3.75 | +0.31 | +9.0% | $3.45 | $3.77 | $3.435 | 730,300 | |
| $3.44 | +0.20 | +6.2% | $3.24 | $3.57 | $3.18 | 590,200 | |
| $3.24 | +0.01 | +0.3% | $3.20 | $3.28 | $3.05 | 469,500 | |
| $3.23 | -0.09 | -2.7% | $3.32 | $3.38 | $3.20 | 212,000 | |
| $3.32 | -0.02 | -0.6% | $3.31 | $3.37 | $3.23 | 396,700 | |
| $3.34 | +0.28 | +9.2% | $3.03 | $3.36 | $3.00 | 634,200 | |
| $3.06 | +0.10 | +3.4% | $2.96 | $3.09 | $2.94 | 422,221 | |
| $2.96 | -0.12 | -3.9% | $3.02 | $3.07 | $2.825 | 837,591 | |
| $3.08 | -0.04 | -1.3% | $3.15 | $3.21 | $3.02 | 682,100 | |
| $3.12 | -0.25 | -7.4% | $3.30 | $3.39 | $3.03 | 716,100 | |
| $3.37 | +0.38 | +12.7% | $3.07 | $3.50 | $3.06 | 1,036,100 | |
| $2.99 | -0.03 | -1.0% | $3.03 | $3.13 | $2.97 | 353,400 | |
| $3.02 | +0.01 | +0.3% | $3.03 | $3.09 | $2.83 | 558,900 | |
| $3.01 | 0.00 | 0.0% | $2.99 | $3.08 | $2.862 | 703,800 | |
| $3.01 | -0.17 | -5.3% | $2.95 | $3.35 | $2.75 | 1,267,500 | |
| $3.18 | +0.35 | +12.4% | $2.76 | $3.211 | $2.72 | 1,935,600 | |
| $2.83 | -1.00 | -26.1% | $3.85 | $4.00 | $1.90 | 12,116,500 | |
| $3.83 | +0.10 | +2.7% | $3.72 | $3.985 | $3.72 | 999,100 | |
| $3.73 | -0.02 | -0.5% | $3.78 | $3.90 | $3.62 | 1,242,000 | |
| $3.75 | +0.62 | +19.8% | $3.14 | $3.77 | $3.13 | 1,395,500 | |
| $3.13 | -0.03 | -0.9% | $3.20 | $3.318 | $3.07 | 668,700 | |
| $3.16 | +0.12 | +3.9% | $3.02 | $3.25 | $3.02 | 926,100 | |
| $3.04 | +0.39 | +14.7% | $2.70 | $3.045 | $2.70 | 1,135,000 | |
| $2.65 | -0.22 | -7.7% | $2.84 | $2.85 | $2.63 | 749,700 | |
| $2.87 | -0.05 | -1.7% | $2.95 | $3.00 | $2.805 | 638,300 | |
| $2.92 | +0.01 | +0.3% | $2.90 | $3.09 | $2.89 | 944,100 | |
| $2.91 | 0.00 | 0.0% | $2.90 | $3.05 | $2.74 | 1,723,800 | |
| $2.91 | +0.30 | +11.5% | $2.64 | $2.99 | $2.62 | 985,200 | |
| $2.61 | -0.07 | -2.6% | $2.72 | $2.83 | $2.60 | 855,400 | |
| $2.68 | +0.15 | +5.9% | $2.585 | $2.78 | $2.49 | 1,610,700 | |
| $2.53 | +0.30 | +13.5% | $2.24 | $2.56 | $2.125 | 3,025,900 | |
| $2.23 | -0.02 | -0.9% | $2.25 | $2.30 | $2.195 | 308,300 | |
| $2.25 | -0.11 | -4.7% | $2.35 | $2.42 | $2.23 | 403,100 |
- Ticker
- NASDAQ:PYXS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 2, 2026
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
Latest deck · Sep 9, 2026
Corporate Update (September 2026)
Corporate update · 33 slides
Latest news
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
Oct 2, 2026
Closed $2.14 (-2.3%) on Oct 2, 2026
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
Sep 30, 2026
Closed $2.33 (-19.7%) on Sep 30, 2026
Pyxis Oncology Announces Proposed Public Offering
Sep 29, 2026
Closed $2.33 (-19.7%) on Sep 30, 2026
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
Sep 9, 2026
Closed $3.38 (-13.1%) on Sep 9, 2026
Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board
Sep 8, 2026
Closed $3.89 (0.0%) on Sep 8, 2026
Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
Aug 13, 2026
Closed $3.01 (-5.3%) on Aug 13, 2026
Financings
Public offering of common stock or pre-funded warrants with accompanying common warrants
Oct 2, 2026
Closed: US$110M raised · US$2.9 a share · Warrants at US$3.5 · Leerink Partners +2
Dealers: Leerink Partners (co-lead), Guggenheim Securities (co-lead), Wells Fargo Securities (co-lead)
Buyers: OrbiMed; GordonMD Global Investments; BVF Partners; Coastlands Capital; RTW Investments
Use of proceeds: Advance lead program MICVO through key clinical milestones including planned Phase 3 Headliner trial, plus working capital and general corporate purposes
Announced Sep 29, 2026 · Update Sep 30, 2026 · Closed Oct 2, 2026
Private placement of securities with accompanying warrants
Aug 13, 2026
Closed: US$50M raised
Use of proceeds: Advance MICVO through key clinical milestones and continue patient follow-up so data can mature
Decks
Corporate Update (September 2026)
Corporate update · 33 slides · Sep 9, 2026
Investor Presentation (March 2026)
Investor deck · 43 slides · Mar 23, 2026
Corporate Update (December 2025)
Corporate update · 29 slides · Dec 18, 2025
Investor Presentation (November 2025)
Investor deck · 31 slides · Nov 3, 2025
Pyxis Oncology, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 79 in all · newest Oct 2, 2026 · oldest 2021
- Decks
- 8 decks · latest Sep 9, 2026
Where Pyxis Oncology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PYXS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:PYXS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Pyxis Oncology, Inc.